ArticleClinical case reports2022
Complement inhibitor eculizumab in thrombotic microangiopathy: Single-center case series.
Monika Vitkauskaitė et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it